On July 31, the National Institutes of Health (NIH) held a workshop with the intent of delving into the policies and methods that guide biomedical innovation and ensure public access to discoveries supported by the agency. The forum aimed to address the NIH’s approach to patenting and licensing biomedical inventions. Additional topics included the agency’s contribution to the expansive biomedical research domain, with an emphasis on utilizing knowledge to bolster public health outcomes.
Many within the intellectual property community shared their own perspectives on these issues via written comments submitted to the NIH. We’ve compiled some highlights from their submissions in the graphic linked below.
Check it out to learn what industry leaders and experts have to say about the policies guiding IP and technology transfer in the United States: https://c4ip.org/wp-content/uploads/2023/08/Perspectives-on-IP-and-Technology-Transfer-in-the-US.pdf#new_tab